Washington: Scientists in Singapore claim to have uncovered a new method to target an enzyme that promotes the oestrogen receptor-negative breast cancer, a finding which may pave the way for an effective treatment for the disease.A team from the Genome Institute of Singapore and the National University of Singapore says it has found the way to target the enzyme EZH2 which puts people at risk of developing the oestrogen receptor-negative breast cancer, one of the most aggressive forms of the disease unresponsive to treatment.According to them, the discovery may soon pave the way to develop more effective treatment strategy for aggressive breast cancers associated with EZH2.It has been known that EZH2 enzymatic activity promotes cancer by inactivating some important tumour suppressors, which function as "brakes" to stop tumour growth.Over-expression of EZH2 is often linked to aggressive and rapid spread of breast cancers, the most common cancer in women all over the world.Therefore, EZH2 is an ideal target for breast cancer treatment, says the team whose findings have been published in the `Molecular Cell` journal.The team, led by Dr Qiang Yu, discovered that besides inhibiting tumour suppressor genes through its enzyme activity, EZH2 is also able to promote cancer through the activation of specific genes involved in the cancer pathway, called NF-kB that is associated with the aggressive oestrogen receptor- negative breast cancer.
Ceasefire violation: Pak targets 2 BSF posts in J&K
DDA housing scheme cleared, over 27K flats on offer
No LoP: SC asks Modi govt to clear stand
Jaipur: Air India flight makes emergency landing due to technical fault